Selective inhibitor of nuclear exporter CRM1/XPO1, Selinexor (KPT-330), exhibits remarkable activity against AML leukemia-initiating cells while sparing normal hematopoietic cells Meeting Abstract


Authors: Etchin, J.; Le, B. T.; Berezovskaya, A.; Conway, A. S.; Chen, W. C.; Kentsis, A.; Mansour, M. R.; Stone, R. M.; Galinsky, I. A.; DeAngelo, D. J.; McCauley, D.; Kauffman, M.; Shacham, S.; Wang, J. C. Y.; Kung, A. L.; Look, T.
Abstract Title: Selective inhibitor of nuclear exporter CRM1/XPO1, Selinexor (KPT-330), exhibits remarkable activity against AML leukemia-initiating cells while sparing normal hematopoietic cells
Meeting Title: 106th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 75
Issue: 15 Suppl.
Meeting Dates: 2015 Apr 18-22
Meeting Location: Philadelphia, PA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2015-08-01
Language: English
ACCESSION: WOS:000371597104073
DOI: 10.1158/1538-7445.am2015-4445
PROVIDER: wos
Notes: Meeting Abstract: 4445 -- 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 18-22, 2015 -- Philadelphia, PA -- Source: Wos
Altmetric Score
MSK Authors
  1. Alex   Kentsis
    47 Kentsis